Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications

Overview of attention for article published in Frontiers in Pharmacology, February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 18 X posts from 16 X users, with an upper bound of 166,611 followers.

RT @FrontPharmacol: Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implication…

Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications https://t.co/DM25UTrE6D #pharmacology #openaccess

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 14 additional X posts.